Acelyrin News Today

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as $5.61 and last traded at $5.67, with a volume of 81890 shares changing hands. The stock had previously closed at $5.95. Wall Street Analysts Forecast Growth A number of research analysts have […]

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price objective among […]

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among […]

By Colin Kellaher Madrigal Pharmaceuticals has hired Mardi Dier to replace Alex Howarth as chief financial officer of the clinical-stage biopharmaceutical...

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report) traded down 8.6% on Tuesday . The company traded as low as $7.62 and last traded at $7.63. 538,704 shares traded hands during trading, a decline of 49% from the average session volume of 1,052,227 shares. The stock had previously closed at $8.35. Analyst Upgrades and Downgrades A […]

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s stock price fell 8.6% during trading on Tuesday . The company traded as low as $7.62 and last traded at $7.63. 538,704 shares traded hands during trading, a decline of 49% from the average session volume of 1,052,227 shares. The stock had previously closed at $8.35. Wall Street […]

Acelyrin, Inc. (NASDAQ:SLRN – Get Free Report)’s share price was up 8% during mid-day trading on Thursday . The company traded as high as $8.24 and last traded at $8.23. Approximately 702,455 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 1,040,443 shares. The stock had previously closed […]

Acelyrin (NASDAQ:SLRN – Get Free Report) and Pfizer (NYSE:PFE – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends. Analyst Recommendations This is a summary of recent ratings and […]

NEW YORK, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that...

NEW YORK, Jan. 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC....